News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,350 Results
Type
Article (87998)
Company Profile (825)
Press Release (781508)
Multimedia
Podcasts (196)
Webinars (28)
Section
Business (233275)
Career Advice (4147)
Deals (39884)
Drug Delivery (151)
Drug Development (91427)
Employer Resources (205)
FDA (18395)
Job Trends (17428)
News (397947)
Policy (39970)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (148)
Alliances (56982)
ALS (181)
Alzheimer's disease (1794)
Antibody-drug conjugate (ADC) (348)
Approvals (18576)
Artificial intelligence (627)
Autoimmune disease (163)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (203)
Biotechnology (490)
Bladder cancer (163)
Brain cancer (65)
Breast cancer (667)
Cancer (5053)
Cardiovascular disease (445)
Career advice (3570)
Career pathing (41)
CAR-T (305)
CDC (59)
Celiac Disease (2)
Cell therapy (829)
Cervical cancer (37)
Clinical research (77046)
Collaboration (1824)
Company closure (5)
Compensation (1163)
Complete response letters (73)
COVID-19 (2993)
CRISPR (99)
C-suite (869)
Cystic fibrosis (154)
Data (6283)
Decentralized trials (2)
Denatured (72)
Depression (151)
Diabetes (535)
Diagnostics (7233)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (303)
Drug pricing (225)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100157)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135091)
Executive appointments (1033)
FDA (21586)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1558)
Gene editing (215)
Generative AI (64)
Gene therapy (673)
GLP-1 (1130)
Government (5442)
Grass and pollen (8)
Guidances (385)
Healthcare (20946)
HIV (61)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (292)
Immuno-oncology (59)
Indications (100)
Infectious disease (3280)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (249)
Interviews (816)
IPO (17955)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (69)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (99)
Longevity (16)
Lung cancer (680)
Lymphoma (379)
Machine learning (45)
Management (66)
Manufacturing (855)
MASH (174)
Medical device (15028)
Medtech (15081)
Mergers & acquisitions (22990)
Metabolic disorders (1401)
Multiple sclerosis (163)
NASH (23)
Neurodegenerative disease (355)
Neuropsychiatric disorders (99)
Neuroscience (3118)
Neurotech (1)
NextGen: Class of 2026 (7708)
Non-profit (5112)
Now hiring (66)
Obesity (677)
Opinion (336)
Ovarian cancer (167)
Pain (212)
Pancreatic cancer (231)
Parkinson's disease (301)
Partnered (39)
Patents (512)
Patient recruitment (484)
Peanut (60)
People (66921)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23805)
Phase 2 (33431)
Phase 3 (25196)
Pipeline (5107)
Policy (337)
Postmarket research (3554)
Preclinical (10694)
Press Release (72)
Prostate cancer (247)
Psychedelics (55)
Radiopharmaceuticals (301)
Rare diseases (909)
Real estate (7440)
Recruiting (80)
Regulatory (29041)
Reports (67)
Research institute (2725)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (257)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (177)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (101)
The Weekly (122)
Vaccines (1150)
Venture capital (96)
Weight loss (465)
Women's health (88)
Worklife (21)
Date
Today (89)
Last 7 days (545)
Last 30 days (2624)
Last 365 days (32849)
2026 (2661)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (90)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51569)
Australia (9058)
California (11563)
Canada (3319)
China (1172)
Colorado (490)
Connecticut (501)
Delaware (348)
Europe (118475)
Florida (1692)
Georgia (372)
Hawaii (4)
Idaho (68)
Illinois (966)
India (69)
Indiana (544)
Iowa (24)
Japan (430)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1459)
Massachusetts (8508)
Michigan (358)
Minnesota (666)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3113)
New Mexico (33)
New York (3054)
North Carolina (1612)
North Dakota (10)
Northern California (5531)
Ohio (354)
Oklahoma (22)
Oregon (55)
Pennsylvania (2313)
Puerto Rico (23)
Rhode Island (50)
South America (1662)
South Carolina (65)
South Dakota (1)
Southern California (4465)
Tennessee (177)
Texas (1826)
United States (41714)
Utah (346)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (974)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
There are 870,350 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline
In its 2025 full year and fourth-quarter earnings call, Merck executives touted the merits of recent deals and what CEO Robert Davis called “probably the broadest and widest pipeline we’ve had in years.”
February 3, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT)
February 3, 2026
·
3 min read
Press Releases
Theriva™ Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026
February 3, 2026
·
8 min read
Press Releases
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - February 3, 2026
February 3, 2026
·
1 min read
Press Releases
Mesa Labs Announces Third Quarter Results - February 3, 2026
February 3, 2026
·
16 min read
Press Releases
Amicus Therapeutics Presents New Long-term Data for both Galafold® (migalastat) and POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at the 22nd Annual WORLDSymposium™ 2026
February 3, 2026
·
10 min read
Press Releases
IN8bio to Present at Upcoming Investor and Scientific Conferences in February 2026
February 3, 2026
·
1 min read
Press Releases
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 3, 2026
February 3, 2026
·
1 min read
Press Releases
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis
February 3, 2026
·
5 min read
Press Releases
Enovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 3, 2026
·
1 min read
1 of 87,035
Next
